Insurers: Mental health parity rule will have ‘severe unintended consequences’
(By Rylee Wilson for Becker’s Hospital Review) Insurers and employers are pushing back on new rules that would toughen requirements
Read More
Healthcare Costs
With TV Drug Ads, What You See Is Not Necessarily What You Get
(By Elisabeth Rosenthal for KFF Health News) Triumphant music plays as cancer patients go camping, do some gardening, and watch
Read MorePayers move to ditch deductibles
(By Jakob Emerson for Becker’s Hospital Review) The trend of health insurers launching products without traditional deductibles is accelerating, reflecting
Read MoreThe cost of senior care: Why aging farmers fear the nursing home
(By Juliana Kim, Tim Evans for NPR) RUGBY, N.D. — Cindie Haakenson was relieved when a room opened up at
Read MoreDirect contracting grows: 6 key numbers
(By Jakob Emerson for Becker’s Hospital Review) As healthcare costs continue to rise, a growing number of employers are exploring
Read MoreThe 3 conditions driving healthcare costs up for employers: Report
(By Mariah Taylor for Becker’s Hospital Review) Pharmacy, cancer and musculoskeletal conditions remain the top drivers of increased healthcare costs
Read MoreFAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
(By Juliette Cubanski for The Kaiser Family Foundation Published: Aug 20, 2024) The Inflation Reduction Act of 2022 (the Act),
Read MoreEmployer healthcare costs to rise 9% in 2025: 5 notes
(By Rylee Wilson for Becker’s Hospital Review) The average cost of employer-sponsored healthcare coverage is expected to jump 9% from
Read MoreWhile Medicare Drug Price Negotiations Don’t Apply to Private Insurance, 3.4 Million People with Employer Coverage Take at Least One of the Selected Drugs
(Tammie Smith for The Kaiser Family Foundation published August 14, 2024) Among the 167 million people with employer-sponsored insurance in
Read MoreMajority of weight loss drug prescriptions going to commercially insured patients
(By Jakob Emerson for Becker’s Hospital Review) In 2023, more than 61% of Ozempic prescriptions went to patients with commercial
Read More